ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,040.04
1.10%
US Tech 100
21,156.00
1.15%
Dow Jones
43,297.03
0.91%
Brent Oil
73.185
0.67%
Bitcoin
98,953.55
4.50%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Germany
  5. TG

  6. Novo Nordisk (NOV) Quote

Novo Nordisk

Novo Nordisk (NOV)

Novatti Group Limited
NOV Inc
85.56
3.80
(4.65%)
Closed December 24 4:00PM
Realtime Data

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
85.56
Bid
85.42
Ask
85.69
Volume
472,482
82.60 Day's Range 87.01
71.01 52 Week Range 139.88
Market Cap
384.679B
Previous Close
81.76
Open
84.50
Last Trade
2
@
85.4
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
90,945
Shares Outstanding
4,496,011,436
Dividend Yield
86.34%
PE Ratio
4.73
Earnings Per Share (EPS)
18.61
Revenue
232.26B
Net Profit
83.68B

About Novo Nordisk

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.novonordisk.com
Headquarters
Bagsvaerd, Dnk
Founded
-
Novo Nordisk is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker NOV. The last closing price for Novo Nordisk was 81.76 €. Over the last year, Novo Nordisk shares have traded in a share price range of 71.01 € to 139.88 €.

Novo Nordisk currently has 4,496,011,436 shares outstanding. The market capitalization of Novo Nordisk is 367.59 € billion. Novo Nordisk has a price to earnings ratio (PE ratio) of 4.73.

Ask ADVFN Intelligence (AI)

NOV Latest News

More News

Novo Nordisk A/S - share repurchase programme

Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 20 December 2024 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of...

December 20 2024
UK Regulatory

Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight in the REDEFINE 1 trial

Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight in the REDEFINE 1 trial Bagsværd, Denmark, 20 December 2024 – Novo Nordisk today announced...

December 20 2024
UK Regulatory

The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is completed

The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is completed Bagsværd, Denmark, 18 December 2024 — Today...

December 18 2024
UK Regulatory

Novo Nordisk A/S - share repurchase programme

Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 16 December 2024 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of...

December 16 2024
UK Regulatory

Novo Nordisk invests DKK 8.5 billion in new production facility in Odense, Denmark

Novo Nordisk invests DKK 8.5 billion in new production facility in Odense, Denmark Bagsværd, Denmark, 16 December 2024 – Today, Novo Nordisk announced plans to invest 8.5 billion Danish kroner to...

December 16 2024
UK Regulatory

Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close

Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close Bagsværd, Denmark...

December 14 2024
UK Regulatory

Novo Nordisk A/S: European regulatory authority adopts positive opinion for an update of the Ozempic® label to reflect risk reduction of kidney disease-related events

Novo Nordisk A/S: European regulatory authority adopts positive opinion for an update of the Ozempic® label to reflect risk reduction of kidney disease-related events Bagsværd, Denmark, 12...

December 12 2024
UK Regulatory

Novo Nordisk A/S - share repurchase programme

Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 9 December 2024 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of...

December 09 2024
UK Regulatory

The European Commission approves the acquisition of Catalent by Novo Holdings and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings

The European Commission approves the acquisition of Catalent by Novo Holdings and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings Bagsværd, Denmark, 6...

December 06 2024
UK Regulatory

Novo Nordisk A/S - share repurchase programme

Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 2 December 2024 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of...

December 02 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-17.54-17.0126091174103.1104.971.0124609786.28250173DE
4-16.22-15.9363332678101.7810771.0111141693.79200551DE
12-21.9-20.3796761586107.46111.3871.019094599.10630729DE
26-47.78-35.8332083396133.34139.8871.0174924109.05553994DE
52-7.54-8.0988184747693.1139.8871.0171447111.75227032DE
156-6.14-6.6957470010991.7139.8871.0169517107.64971266DE
260-6.14-6.6957470010991.7139.8871.0169517107.64971266DE

NOV - Frequently Asked Questions (FAQ)

What is the current Novo Nordisk share price?
The current share price of Novo Nordisk is 85.56 €
How many Novo Nordisk shares are in issue?
Novo Nordisk has 4,496,011,436 shares in issue
What is the market cap of Novo Nordisk?
The market capitalisation of Novo Nordisk is EUR 367.59B
What is the 1 year trading range for Novo Nordisk share price?
Novo Nordisk has traded in the range of 71.01 € to 139.88 € during the past year
What is the PE ratio of Novo Nordisk?
The price to earnings ratio of Novo Nordisk is 4.73
What is the cash to sales ratio of Novo Nordisk?
The cash to sales ratio of Novo Nordisk is 1.7
What is the reporting currency for Novo Nordisk?
Novo Nordisk reports financial results in DKK
What is the latest annual turnover for Novo Nordisk?
The latest annual turnover of Novo Nordisk is DKK 232.26B
What is the latest annual profit for Novo Nordisk?
The latest annual profit of Novo Nordisk is DKK 83.68B
What is the registered address of Novo Nordisk?
The registered address for Novo Nordisk is NOVO ALLE, BAGSVAERD, DK-2880
What is the Novo Nordisk website address?
The website address for Novo Nordisk is www.novonordisk.com
Which industry sector does Novo Nordisk operate in?
Novo Nordisk operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
0RARAPT Therapeutics Inc
1.61 €
(101.25%)
83.81k
KASHIntellabridge Technology Corp
0.047 €
(88.00%)
1.24M
4APApollo Minerals Ltd
0.01 €
(66.67%)
30
AWY0Percheron Therapeutics Ltd
0.007 €
(55.56%)
660k
1W81WISeKey International Holding Ltd
9.70 €
(44.78%)
4.81k
WWTWater Ways Technologies Inc
0.0045 €
(-95.91%)
2.53k
L7C2Windfall Geotek Inc
0.0025 €
(-70.59%)
40k
QP9Atco Mining Inc
0.003 €
(-55.88%)
1.5k
0PV2Moovly Media Inc
0.002 €
(-55.56%)
500
8QPFidus Investment Corp
9.5899 €
(-51.32%)
220
D7GNel ASA
0.2496 €
(-0.79%)
3.89M
RQ0DWave Quantum Inc
7.896 €
(24.07%)
2.16M
FWR0Yumy Candy Company Inc the
0.0352 €
(40.80%)
2.12M
PF8European Lithium Limited
0.0204 €
(-0.97%)
2.07M
DI6Distribuidora Internacional De Alimentacion SA
0.017 €
(1.80%)
1.83M

Discussion

View Full Feed
pos_stock_hoarder pos_stock_hoarder 1 minute ago
I can't tell either!

https://assets.amuniversal.com/21ac52a0a41c013d8512005056a9545d
crazy horse 0 crazy horse 0 1 minute ago
Trump vows to direct DOJ to pursue death penalty in wake of Biden clemencies

“As soon as I am inaugurated, I will direct the Justice Department to vigorously pursue the death penalty to protect American families and children from violent rapists, murderers, and monsters,” Trump said
resx18 resx18 1 minute ago
Great green close! $AURI
AURI
GREGG THE GREEK GREGG THE GREEK 1 minute ago
100% Rig


Same to you and all who contribute here.


Wishing you all the best !!!
Iceman Iceman 1 minute ago
All Time high closing price today, $44.58.

Merry Christmas!

Ice
IONQ
pos_stock_hoarder pos_stock_hoarder 1 minute ago
I can't tell either!

https://assets.amuniversal.com/21ac52a0a41c013d8512005056a9545d
88TH MAN 88TH MAN 2 minutes ago
FBEC Last Price: $0.0005 +0.0005 (+49,900.00%).
FBEC
i_like_bb_stock i_like_bb_stock 2 minutes ago
Thx
tw0122 tw0122 2 minutes ago
Nice W on bottom monthly and .68 break again eventually 

GREGG THE GREEK GREGG THE GREEK 2 minutes ago
Shaping up nicely for the bigger move.


RVPH
RVPH
Mark Mark 3 minutes ago
Yea, still waiting on it
glenn1919 glenn1919 3 minutes ago
CISO.......................https://stockcharts.com/h-sc/ui?s=CISO&p=W&b=5&g=0&id=p86431144783
CISO
stock1ace1 stock1ace1 3 minutes ago
NEW YORK, Dec. 20, 2024 /PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing therapeutics for neurodegenerative disorders, today announced that its Board of Directors has formed an independent Special Committee to explo
pos_stock_hoarder pos_stock_hoarder 3 minutes ago
I can't tell either!

https://assets.amuniversal.com/21ac52a0a41c013d8512005056a9545d
Ecomike Ecomike 3 minutes ago
Merry Christmas MrKirby
IFUS
stock1ace1 stock1ace1 3 minutes ago
NEW YORK, Dec. 20, 2024 /PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing therapeutics for neurodegenerative disorders, today announced that its Board of Directors has formed an independent Special Committee to explo
al44 al44 3 minutes ago
Pssst, hey Nancy-

https://media.gettr.com/group7/getter/2024/12/24/17/d30f2d6b-b770-dcb6-3748-f9ab00f85e2e/a25c6971ac0e51f53198282fe0711573_768x0.png
Mark Mark 4 minutes ago
$CLEU 3.59
CLEU
trunkmonk trunkmonk 4 minutes ago
Pretty much end of year stuff, taking losses or gains, switching between GSEs to avoid cap gains tax.
FNMA
stock1ace1 stock1ace1 4 minutes ago
SNPX 1 Mill Float $19.6Mill cash on balance sheet = $15 Cash Per share !!
al44 al44 4 minutes ago
'Ok, Who Got Me The MAGA Hat?' Asks Kamala Harris As Jill Biden Stifles Laughter

https://media.babylonbee.com/articles/676ae98d72b3a676ae98d72b3b.jpg

WASHINGTON, D.C. — The traditional unwrapping of presents at the White House took an awkward turn this morning when Jill
ProfitChaser ProfitChaser 4 minutes ago
Merry Christmas to you also and everyone. All I want Santa to bring me is a RV. LOL.
Lime Time Lime Time 5 minutes ago
Santa run in the making 🚀
EEGI
nelson1234 nelson1234 5 minutes ago
Merry Xmas Xroad boyz and galz!
Ecomike Ecomike 5 minutes ago
Happy holidays to you too and all the IFUS Long Knives here. The only ones that are not fooled by basher tard lies they are paid by hedge funds in trouble, to post.
IFUS

Your Recent History

TG
NOV
Novo Nordisk
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads